TNFRSF13C and non-Hodgkin lymphoma: The salivary glands of primary Sjögren’s disease patients who experienced neoplastic progression were enriched with BAFF-R (fold change: 4.78 ± 1.61) compared to both primary Sjögren’s disease patients who did not develop NHL (fold change: 1.05 ± 0.20; p = 0.002) and sicca disease patients (fold change: 0.52 ± 0.06; p = 0.003) (Figure 3B).